Senior insider sale
Chief Strategy Officer at OCULAR THERAPEUTIX, INC — senior position signals high conviction
$130.7K
13.98K shares
What this filing means
NAYAK SANJAY plans to sell 13.98K shares of OCULAR THERAPEUTIX, INC valued at approximately $130.7K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 2/23/2026ACC: 0001950047-26-001622
Officer· Chief Strategy Officer
Since Feb 2026
13.98K
Shares to sell
$130.7K
Approx. market value
1.76K
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months1
Restricted stock vesting under a registered plan
Not Applicable
2/22/2026
1.76KTotal acquired1.76K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
2/22/2026 | Restricted stock vesting under a registered plan Not Applicable | 1.76K | — |
| Total | 1.76K | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
10.35K
Market value
$93.6K
2/12/2026
—Completed
Units to sell
1.88K
Market value
$22.6K
11/24/2025
Planned — Approximate Date
NASDAQPlanned
Units to sell
1.76K
Market value
$14.6K
2/23/2026
Total
Units
13.98K
Value
$130.7K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
2/12/2026 | 10.35K | $93.6K | — | Completed |
11/24/2025 | 1.88K | $22.6K | — | Completed |
| Planned — Approximate Date | ||||
2/23/2026 | 1.76K | $14.6K | NASDAQ | Planned |
| Total | 13.98K | $130.7K | ||